NanoEcho CEO Linda Persson was recently interviewed by Aktiespararna, where she talks about NanoEcho, the next steps in our clinical programme, how our diagnostics could potentially contribute to better decision-making in healthcare, the market potential, and our ongoing rights issue.
Listen to the interview in Aktiespararna’s podcast (around 30:30 in)!
Watch the video interview here!
NanoEcho is currently conducting a rights issue. The subscription period runs until 27 February 2026. Read more about the issue here!